key: cord-0833096-kj966fnd
authors: Cataldi, Mauro; Pignataro, Giuseppe; Taglialatela, Maurizio
title: Neurobiology of coronaviruses: Potential relevance for COVID-19
date: 2020-07-02
journal: Neurobiol Dis
DOI: 10.1016/j.nbd.2020.105007
sha: bbcbb0bcba37ee19c283531060ff38a1cf2177a7
doc_id: 833096
cord_uid: kj966fnd

In the first two decades of the 21st century, there have been three outbreaks of severe respiratory infections caused by highly pathogenic coronaviruses (CoVs) around the world: the severe acute respiratory syndrome (SARS) by the SARS-CoV in 2002–2003, the Middle East respiratory syndrome (MERS) by the MERS-CoV in June 2012, and Coronavirus Disease 2019 (COVID-19) by the SARS-CoV-2 presently affecting most countries In all of these, fatalities are a consequence of a multiorgan dysregulation caused by pulmonary, renal, cardiac, and circulatory damage; however, COVID patients may show significant neurological signs and symptoms such as headache, nausea, vomiting, and sensory disturbances, the most prominent being anosmia and ageusia. The neuroinvasive potential of CoVs might be responsible for at least part of these symptoms and may contribute to the respiratory failure observed in affected patients. Therefore, in the present manuscript, we have reviewed the available preclinical evidence on the mechanisms and consequences of CoVs-induced CNS damage, and highlighted the potential role of CoVs in determining or aggravating acute and long-term neurological diseases in infected individuals. We consider that a widespread awareness of the significant neurotropism of CoVs might contribute to an earlier recognition of the signs and symptoms of viral-induced CNS damage. Moreover, a better understanding of the cellular and molecular mechanisms by which CoVs affect CNS function and cause CNS damage could help in planning new strategies for prognostic evaluation and targeted therapeutic intervention.

The high neurotropism of -CoVs in experimental animals has been known for decades. In fact, the first evidence that CoVs may infect the CNS was gathered at the end of 1940s when a neurotropic strain of the -CoVs mouse hepatitis virus-4 (MHV-4), the JHM virus (JHMV) named in honor of the microbiologist John Howard Mueller 6 , was isolated from mice developing spontaneous hind leg paralysis, and was shown to induce a diffuse encephalomyelitis with patchy areas of demyelination when inoculated in mice 7, 8 . In newborn and weanling rats, JHMV induces either an acute panencephalomyelitis, which is usually fatal in a few days, or a subacute paralytic disease which progresses over several months, or a chronic progressive paralysis appearing 6-8 month after virus inoculation 9 . These conditions differ significantly in their gross and microscopic pathology with widespread neuronal death, necrosis and polymorphonucleate infiltration in the acute form, perivascular cuffing consisting of plasma cells and macrophages and large demyelinating lesions in which axons are largely preserved in the subacute form, and diffuse myelomalacia, cerebral cortex thinning and hydrocephalus in the chronic form 9, 10 , suggesting multiple pathogenic mechanisms. The demyelinating lesions found in the subacute paralytic disease displayed considerable histopathological resemblance to those of multiple sclerosis (MS); therefore, JHMV infection has become a widely used experimental model for this disease 11 . JHMV is not the only neurovirulent CoV in rodents. In fact, a few years after its identification, Dick et al. 12 isolated a mutant neurotropic strain of the mouse hepatitis virus-3 (MHV-3), that did not cause hepatitis but induced a fatal meningo-encephalitis when injected intracerebrally in mice. It was later reported that, in a few susceptible mice strains such as CH3 and AG2 mice, also the wild type MHV-3 variant induced neurological manifestations with lack of coordination and limb paresis associated to histological evidence of brain vasculitis and meningoependymitis 13 . Interestingly, CoVs may induce neurological diseases also in species different from rodents, as seen in the -CoV porcine hemagglutinating encephalomyelitis virus (PHEV) of the VW572 strain that causes encephalomyelitis in piglets 14 , and the feline -CoV (FCoV) that produces significant CNS damage in cats 14 .

the BBB 27 . Indeed, neutrophils, macrophages, and natural-killer (NK) lymphocytes may support MHV replication in the early stages of the infection, and can be recruited in MHV-infected brain tissue 28 . Moreover, different strains of CoVs, including SARS-CoV, infect peripheral myeloid cells during respiratory infections, and infected leukocytes can serve as reservoirs for CNS invasion 29-32 . On the other hand, CoVs can also directly penetrate the brain causing meningeal inflammation and damage to the integrity of the BBB through the release of inflammatory mediators 33 CoV receptors. The ability of CoVs to enter the primary infection site and to later spread to distant sites including the CNS, relies on their interaction with specific receptors located on the host cells.

A large body of experimental work firmly points to the spike (S) protein as the main determinant of cell tropism and pathogenicity of CoVs 40 . The S protein, which forms heavily glycosylated transmembrane trimers in the viral envelope, mediates CoVs entry into susceptible host cells via the interaction with specific cellular receptors represented by aminopeptidase N (APN) for the α-subunits contained in the same protein, the N-terminal surface subunit (S1) responsible for receptor binding, and the C-terminal transmembrane subunit (S2) that mediates viral internalization 49 . Upon binding to its receptor, the S protein is cleaved by specific proteases, thereby allowing the release of the S2 subunit, initiating membrane fusion and virus internalization 49 . Cleavage of SARS-CoV 50 and SARS-CoV-2 43 S protein is mediated by the Transmembrane Serine Protease 2 (TMPRSS2); pharmacological inhibition of TMPRSS2 significantly reduces infection with SARS-CoV-2, representing therefore a potential strategy for the treatment of COVID-19 51 . The ability of MHVs to invade the CNS by the neurogenic route was demonstrated by sequential immunochemistry analysis showing that, after intranasal inoculation in mice, JHMV first infects the nasal mucosa and then progresses into the brain through the olfactory fibers to reach the anterior part of the brain and, after at least four days, invade the posterior regions 57 . In this model, the trigeminal nerve may also be infected by JHMV 58 ; however, since no brain infection occurs in mice upon removal of the olfactory bulbs, it is clear that the trigeminal route is not a major invasion pathway 59 . Brain invasion through the olfactory fibers has also been demonstrated hippocampus, the brain stem where it can damage the respiratory nuclei, and, finally, the cortex and the spinal cord 38, 61 . Destruction of the olfactory epithelium with zinc sulphate abrogated brain invasion, further supporting the critical role of olfactory fibers for neuroinvasion; by contrast, hematogenous invasion was ruled out because viral particles were not found in the general circulation after intranasal viral inoculation 38 . Finally, although HCoV-OC43 may cause gastroenteritis in humans, no evidence for its propagation to the CNS though the vagal route has been reported so far.

Neuroinvasion by SARS-CoV and MERS-CoV. The mechanism of neuroinvasion by SARS-CoV has been investigated in the above mentioned K18-hACE2 transgenic mice overexpressing the human ACE2, a valuable experimental model of human SARS 62 . The analysis of brains collected at serial times after virus inoculation in these transgenic mice showed that the virus enters the brain through the olfactory bulb to be rapidly cleared from these neurons, followed by spreading to more distal regions.

Remarkably, not only regions directly connected with the olfactory bulb (including the piriform cortex, the basal ganglia and the midbrain), but also regions with no direct synaptic connection are rapidly invaded, suggesting that alternative routes of invasion besides the transsynaptic propagation could be involved, possibly including the Virchow-Robin spaces. The dorsal vagal complex is among the brain structures not directly connected with the olfactory bulb which are invaded early during the disease. Its damage could thus contribute to the death of the animal by cardiorespiratory failure. The route used by SARS-CoV to invade the dorsal vagal nuclei is still unclear, but it does not likely involve the propagation from the gut through the vagal fibers since the virus has not been found in the gut after intranasal instillation. Importantly, after intranasal administration, SARS-CoV-2 can be found only in neurons, with no glial colonization or inflammatory cell infiltration, ruling out the spread to the CNS through the hematogenous route 62 . Notably, the pattern of neuroinvasion by SARS-CoV emerging from studies in K18-hACE2 transgenic mice is different from that observed by Glass et al. 22 in wild type C57 mice. This study found no evidence of olfactory bulb involvement and the location of the virus was predominantly in the hippocampus, an area frequently spared or only slightly and lately infected in transgenic mice. It is presently unknown whether this different neuroinvasion pattern occurs because SARS-CoV penetrates the brain through alternative routes in the absence of high affinity hACE2 J o u r n a l P r e -p r o o f Journal Pre-proof receptors, or because it is simply a consequence of the slow progression of brain infection in wild type mice.

The mechanism of neuroinvasion by MERS-CoV has not been investigated so far. However, the occurrence of perivascular infiltrates in the brainstem and meningitis in the cortex of hCD26/DPP4 transgenic mice is hardly compatible with a neurogenic pattern of infection, and better fits with hematogenous invasion 26 .

In vitro experiments using murine or human cell cultures exposed to JHMV, HCoV-OC43, or SARS-CoV have shown that CoVs can infect neurons, glial cells and BMECs [63] [64] [65] [66] . Importantly, neuronal and glial cells infected in vitro or in vivo may harbor CoVs for a very long time 67-72 , possibly accounting for their long persistence in the brain after the initial infection and for their potential involvement in chronic neurodegenerative diseases 11 (see below). Non-neuronal cells have a role in the neurobiology of CoV infection of the CNS since they may be instrumental for tissue damage or healing. In addition, their dysfunction contributes to the pathogenesis of relevant neurological disorders such as stroke [73] [74] [75] or seizures 76-78 that can complicate severe brain infection by CoVs.

Evidence has been reported that JHMV may kill cultured oligodendrocytes by promoting apoptosis 79, 80 , and that HCoV-OC43 may induce an unfolded protein response causing necroptosis in neuronal cells 81, 82 . Direct virus-induced cell demise may have a role in acute or hyperacute forms of CoV-induced CNS damage which occur with limited tissue inflammation in mice 62 or humans 83 . In the majority of cases, however, CoV neuroinvasion triggers a major immune response with tissue inflammation that can either clear the virus and help resolving the infection, or cause immune-mediated CNS injury. Importantly, even when CoVs are no longer detectable, sterile immunity is rarely achieved since the virus persists in the brain in a latent form.

specific CoV-induced neuroinfection will evolve to resolution, progression, or chronicization, depends on a fine balance between factors that promote or restrain inflammatory responses 84 .

While the activation of both innate and adaptive immune responses is crucial for CoVs clearance and infection healing, the release of inflammatory mediators may seriously damage the CNS.

Studies on JHMV-induced neuroinfection in mice unveiled a specific temporal sequence of the J o u r n a l P r e -p r o o f Journal Pre-proof immune response: once inside the CNS, the virus triggers innate immunity with significant polymorphonucleate, macrophage and NK cell infiltration. The release of cytokines and chemokines causes tissue damage, and eventually long lasting adaptive immunity is established, thus eradicating the infection or initiating CNS autoimmune aggression 28 . Early activation of innate immunity is associated with the release of INF/by microglial cells. A strong INF response predicts the resolution of the infection, whereas a weak response is associated to a higher risk of virus persistence and chronic CNS infection 28, 84 . Wheeler et al. 85 recently reported that microglial activation is essential for the survival of mice with a severe JHMV variant-induced encephalitis.

Proinflammatory cytokines and chemokines, including IL-1, IL-1, IL-6, IFN-, TNF-α, and CXCL10 are released by CNS resident cells (macrophages, glial and endothelial) as well as by infiltrating cells as part of the innate immunity response, and play a crucial role both in damaging the nervous tissue and in the subsequent activation of the adaptive immunity 86 . As a matter of fact, it has been demonstrated that there is a correlation between the levels of the mRNAs for some of the aforementioned mediators of the innate immune response (such as TNF-, IL-12 p40, IL-6, IL-15, and IL-1) and the neurovirulence of different MHV strains, further strengthening the role of these cytokines as master regulators of CoV neurovirulence 87 . In fact, IL-1 and IL-6 mRNA transcription is robustly activated in mice brains following infection with the neurovirulent JHMV, but not with the more attenuated MHV-A59 strain 88 . Moreover, high levels of IL-1β were found in brain-derived CD11 + cells, microglia, and macrophages from MHV intracranially-infected mice. Survival of these mice was increased by treatment with the IL-1 receptor antagonist (IL-Ra) anakinra 89, 90 .

The pathophysiological relevance of some of these mechanisms also receives support from studies Although responsible for demyelination, immune response is also essential to prevent the reactivation of a latent CNS CoV infection. In fact, reactivation of JHMV infection has been shown to occur in mouse models in which humoral immunity is impaired. For example, in μMT mice that lack mature B cells JHMV are not persistently cleared from the CNS as in wild type mice, but, after a transitory clearance by cell immunity, remerge mainly in oligodendrocytes and cause encephalitis and animal death 122, 123 .

More than thirty years ago, seizures and signs of meningitis or radiculitis in patients with serologically proven HCoV-OC43 infection were first reported 124 . Nonetheless, the etiological involvement of CoVs in acute encephalitis in humans has only been demonstrated in immunosuppressed patients. The presence of HCoV-OC43 in a brain biopsy sample from a 11month old boy with severe combined immunodeficiency and signs and symptoms of encephalitis was demonstrated using RNA sequencing and confirmed by real-time PCR and immunocytochemistry 83 . The radiological findings in this child did not show demyelination but an extensive gray matter damage with loss of brain volume. Very recently, the presence of the HCoV-OC43 genome has been documented in a brain biopsy sample from a 19 month-old child affected with pre-B acute lymphoblastic leukaemia who developed a persistent airway disease during chemotherapy followed by a fatal encephalitis 125 .

CoVs may also play a role in the genesis of acute disseminated encephalomyelitis (ADEM), a monophasic autoimmune demyelinating disease usually occurring in children a few days after an infection or a vaccination 126, 127 . The histopathological features of ADEM are similar to those observed in the subacute form of JHMV-induced encephalitis in rats, with perivascular sleeves of demyelination abundantly infiltrated by T cells but not by polymorphonucleates 126, 127 . Moreover, the case of a 15 year-old boy who developed ADEM with numbness in the lower limbs a week J o u r n a l P r e -p r o o f Journal Pre-proof after a common cold and whose CSF was positive for HCoV-OC43 at RT-PCR analysis 128 , further supports a potential link between CoVs infection and subacute demyelinating diseases in humans.

Intriguingly, a common laboratory finding in ADEM patients is the significant increase in CSF levels of several cytokines and chemokines, also including those induced upon CoV infection in experimental animals, such as IL-6, IFN-γ, TNF-α, CXCL9, and CXCL10 129 .

However, it is presently unknown whether highly pathogenic SARS-CoV and MERS-CoV can also cause encephalitis in humans, possibly because of the difficulties in identifying symptoms and signs of brain involvement in patients who are deeply sedated during mechanical ventilation, and due to the limited availability of autoptic material. Nonetheless, genome sequences of SARS-CoV have been found in brain samples from all eight SARS-affected patients reported by Gu et al. 130 who underwent a thorough autoptic examination, with neuronal death and necrosis at histopathology in 6 of them. Moreover, the SARS-CoV genome was identified by RT-PCR in the CSF of a 32 year-old woman affected with SARS who developed generalized tonic-clonic seizure 131 , and in brain autoptic samples from a 39 year-old patient who died from SARS and showed neurological symptoms suggestive of encephalitis 102 . In addition, three patients with MERS-CoV infection displayed severe neurological impairment, which variably included altered mental status from confusion to coma, ataxia and focal motor deficits, and MRI findings suggestive of ongoing encephalitis 132 . As far as the involvement of the CNS during infection with SARS-CoV-2 is concerned, it has been suggested that neurological symptoms frequently occurring at the onset of COVID-19 133,134 may represent early warning signs of the disease 135 . In a retrospective analysis of 214 COVID-19 patients admitted to three hospitals in Wuhan, China, neurological signs were observed in more than 36% of the cases 133 . Although in the majority of cases these neurological symptoms were mild and consisted in headache, dizziness augeusia and hyposmia, altered consciousness or stroke also occurred 133 . Additional reports documenting serious neurological complications in COVID-19 patients have been subsequently published. For instance, a severe encephalopathy with diffuse EEG slowing was described in a 74-year-old man presenting with altered mental status and later shown to be affected with COVID-19 136 . Altered mental status at presentation was also documented in a middle-aged female whose CT scan was diagnostic for acute hemorrhagic necrotizing encephalopathy (ANE), a rare complication of influenza and other viral infections causing BBB breakdown but without direct viral invasion or parainfectious demyelination (intracranial cytokine storm) 137 lesions of the brain and spinal cord resembling those observed in acute MHV infection 140 . It has also been hypothesized (but not formally proven) that SARS-CoV-2-induced acute encephalopathic damage of the brainstem respiratory centers may contribute to the respiratory failure observed in seriously affected COVID-19 patients. 141 Among the acute neurological complications of SARS-CoV-2 worth mentioning is stroke, whose prevalence is highly increased in COVID-19 just as it was in SARS 142, 143 . In a retrospective series 133 , stroke occurred in about 5.7% of severely-affected COVID-19 patients, whereas its prevalence was 2.5% among 388 consecutive COVID-19 patients admitted to a University hospital in Milan 144 . Remarkably, stroke in COVID-19 patients may occur at a much younger age than in the general population, often in the absence of classical risk factors 145 and ophthalmoplegia, has also been reported in two COVID-19 patients 161 .

The profile of CoVs as neurovirulent agents is not only that of rapid-acting killers, but also of slowacting saboteurs. As previously mentioned, CoVs may remain in the CNS of experimental animals for a very long time after an acute infection, possibly inducing slowly progressing tissue damage through immunological mechanisms. The histopathologic and pathogenetic similarities between experimental CoV infections in rodents and human demyelinating diseases such as MS have already been highlighted 9, 10, 162 . One of the first evidence supporting CoVs role in the pathogenesis of MS comes from the electron microscopic identification of donut-shaped CoV-like particles in the active brain lesions of a young woman deceased with MS 163 . A few years later, two CoVs similar to HCoV-OC43 (named SK and SD) were isolated from autoptic cerebral samples of two MS patients 164 . These two viruses induced encephalitis with demyelination when intracerebrally injected in non-human primates 16 . However, the etiological role for the SK and SD viruses in MS in these patients has not been firmly established, and the possibility that they could represent a murine contaminant has never been excluded 165 . HCoV-OC43 and HCoV-229E RNA and/or antigens have also been detected in brain samples from MS patients [166] [167] [168] . Moreover, T cells cross-reacting to myelin basic protein and human CoVs antigens were isolated from peripheral blood 169 , and intrathecal synthesis of antibodies to HCoV-OC43 and HCoV-229E was documented in MS patients 170 .

Among neurodegenerative diseases, it should be mentioned that CoVs could also take part in the pathogenesis of Parkinson's disease (PD), mainly based on the observation that basal ganglia are damaged during experimental CoV infection both in rodents and primates 171, 172 . However, only one human study has shown higher titers of antibodies against JHMV and HCoV-OC43 in the CSF of PD patients when compared to normal age-matched controls 173 .

It is worth noticing that, by promoting the local release of cytokines such as IL-1 and IL-6, CoVs could actually trigger a more general pathogenic mechanism of CNS damage that is activated in many chronic neurodegenerative diseases including MS, Alzheimer, Parkinson disease, and epilepsy, also in the absence of documented viral infections [174] [175] [176] . However, no direct finding supporting this hypothesis is currently available.

The evidence examined in the present review highlights the long-known but currently littleconsidered ability of CoVs to invade the CNS and cause neurological diseases.It also shows, however, that most of our knowledge of CoV neurovirulence derives from studies performed in rodents infected with MHVs or HCoV-OC43. On the other hand, the information on the new human CoVs is much more limited. Many basic questions concerning the neurobiology of these new viruses still need to be addressed in experimental animals, and major clinical points concerning CoVs infections in human patients remain to be urgently clarified for SARS-CoV-2 in light of the devastating health consequences of the ongoing COVID-19 pandemic. Reliable animal models are critical to successfully address these issues 177 . In fact, both MERS and SARS can hardly be replicated in rodents, and transgenic animals overexpressing the receptors for their causative viruses display a non-physiological distribution pattern of CoV receptors in the CNS which does not faithfully replicate the neurobiology of these viruses 23, 25 . Moreover, even in hACE2 overexpressing mice, no evidence of CNS invasion was detected upon experimental infection with SARS-CoV-2 24 ; thus, better animal models of SARS-CoV-2 neuroinvasion and/or different experimental conditions for neuroinfection are also needed.

Many questions regarding the neurological consequences of COVID-19 in humans are still unanswered. For instance, it is currently unknown whether the neurological signs described in COVID-19 patients are a consequence of a direct SARS-CoV-2 CNS infection; however, the fact that SARS-CoV-2 genome has been isolated from the CSF of a COVID-19 patient 178 suggests direct viral neuroinvasion. Further attempts to isolate SARS-CoV-2 from the CSF, and autopsies of COVID-19 victims may shed some light. In addition, knowing whether the encephalopathy occurring during the acute phase of the disease leads to long lasting sequelae such as chronic epilepsy or cognitive impairment would be critical for rigorous prognostic evaluation; however, we presently don't know whether SARS-CoV-2 establishes latent infections that could either reactivate or trigger chronic neurological disorders. Shared procedures for early identification of COVID-19 patients at high risk of neurological involvement are essential. In order to better define the extent and pathomechanism of CNS damage, special attention should be given to signs and symptoms that could suggest brainstem impairment. These may then prompt further diagnostic investigations with auditory brainstem responses, neuroimaging tools, or CFS analysis, as recently suggested 179 .

Studies aiming to better characterize the immunological mechanisms responsible for disease pathogenesis could additionally provide solid conceptual basis for the rational use of immune J o u r n a l P r e -p r o o f Journal Pre-proof modulators such as the anti-IFN-emapalumab, the IL-1 antagonist anakinra, and the two monoclonal antibodies targeting the IL-6 pathway sarilumab and tocilizumab. All these drugs, potentially representing targeted therapeutic interventions to prevent or dampen neuroinflammation in COVID-19 patients, are currently under active investigation (https://clinicaltrials.gov/ct2/show/NCT04330638; https://www.clinicaltrials.gov/ct2/show/NCT04339712; https://www.univadis.co.uk/viewarticle/covid-19-italy-launches-an-independent-trial-ontocilizumab-715741).

M.C., G.P, and M.T. wrote the initial draft; they all read, amended, and approved the final manuscript. 

Human coronaviruses: What do they cause? Antivir Ther

Mechanisms of zoonotic severe acute respiratory syndrome coronavirus host range expansion in human airway epithelium

Evidence for zoonotic origins of middle east respiratory syndrome coronavirus

Covid-19: Zoonotic aspects

Pathology of infection with the jhm virus

A murine virus (jhm) causing disseminated encephalomyelitis with extensive destruction of myelin

A murine virus (jhm) causing disseminated encephalomyelitis with extensive destruction of myelin : Ii. Pathology

Early and late cns-effects of corona virus infection in rats

Human coronavirus: Respiratory pathogens revisited as infectious neuroinvasive, neurotropic, and neurovirulent agents

In vitro interaction of coronaviruses with primate and human brain microvascular endothelial cells

Coronavirus infects and causes demyelination in primate central nervous system

Further observations on coronavirus infection of primate cns

Murine encephalitis caused by hcov-oc43, a human coronavirus with broad species specificity, is partly immune-mediated

Growth in suckling-mouse brain of "ibv-like" viruses from patients with upper respiratory tract disease

Is there an ideal animal model for sars?

Antibody targeting of the cc chemokine ligand 5 results in diminished leukocyte infiltration into the central nervous system and reduced neurologic disease in a viral model of multiple sclerosis

Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (sars-cov) pulmonary infection of mice

Lethal infection of k18-hace2 mice 25

Generation of a transgenic mouse model of middle east respiratory syndrome coronavirus infection and disease

Characterization and demonstration of the value of a lethal mouse model of middle east respiratory syndrome coronavirus infection and disease

Neurologic alterations due to respiratory virus infections

Coronavirus infection of the central nervous system: Hostvirus stand-off

In vitro detection of apoptosis in monocytes/macrophages infected with human coronavirus

Activation of human monocytes after infection by human coronavirus 229e

A human coronavirus responsible for the common cold massively kills dendritic cells but not monocytes

Human coronaviruses and other respiratory viruses: Underestimated opportunistic pathogens of the central nervous system? 57. Barthold SW. Olfactory neural pathway in mouse hepatitis virus nasoencephalitis

Spread of a neurotropic murine coronavirus into the cns via the trigeminal and olfactory nerves

The olfactory nerve and not the trigeminal nerve is the major site of cns entry for mouse hepatitis virus, strain jhm

Limbic encephalitis after inhalation of a murine coronavirus

Non-invasive bioluminescence imaging of hcov-oc43 infection and therapy in the central nervous system of live mice

Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ace2

Acute and persistent infection of human neural cell lines by human coronavirus oc43

Infection of primary cultures of human neural cells by human coronaviruses 229e and oc43

Pathogenesis of mouse hepatitis virus-induced demyelination

Stability of neurotropic mouse hepatitis virus (jhm strain) during chronic infection of neuroblastoma cells

Regional localization of virus in the central nervous system of mice persistently infected with murine coronavirus jhm

Persistence of mouse hepatitis virus a59 rna in a slow virus demyelinating infection in mice as detected by in situ hybridization

Persistence of viral rna in the central nervous system of mice inoculated with mhv-4

General pathophysiology of astroglia

Astrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke

The biphasic function of microglia in ischemic stroke

Glia and epilepsy: Excitability and inflammation

Immunity activation in brain cells in epilepsy: Mechanistic insights and pathological consequences

Glia as a source of cytokines: Implications for neuronal excitability and survival

A human coronavirus oc43 variant harboring persistence-associated mutations in the s glycoprotein differentially induces the unfolded protein response in human neurons as compared to wild-type virus

Pivotal role of receptor-interacting protein kinase 1 and mixed lineage kinase domain-like in neuronal cell death induced by the human neuroinvasive coronavirus oc43

Human coronavirus oc43 associated with fatal encephalitis

Fine tuning the cytokine storm by ifn and il-10 following neurotropic coronavirus encephalomyelitis

Microglia are required for protection against lethal coronavirus encephalitis in mice

Interleukin-6 induction in vitro in mouse brain endothelial cells and astrocytes by exposure to mouse hepatitis virus (mhv-4, jhm)

Coronavirus neurovirulence correlates with the ability of the virus to induce proinflammatory cytokine signals from astrocytes and microglia

Differential regulation of innate and adaptive immune responses in viral encephalitis

Interleukin-1 and neuronal injury

Inflammatory mediators in human epilepsy: A systematic review and meta-analysis

Pro-and anti-inflammatory biomarkers and traumatic brain injury outcomes: A review

Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis

Il-6: An early marker for outcome in acute ischemic stroke

Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke

Early tnf-alpha levels correlate with ischaemic stroke severity

Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy

Microglia responses to interleukin-6 and type i interferons in neuroinflammatory disease

Coronavirus infections in the central nervous system and respiratory tract show distinct features in hospitalized children

Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome

Glutamate excitotoxicity is involved in the induction of paralysis in mice after infection by a human coronavirus with a single point mutation in its spike protein

Covid-19 cytokine storm: The interplay between inflammation and coagulation

Virus persistence and recurring demyelination produced by a temperature-sensitive mutant of mhv-4

Coronavirus jhm omp1 pathogenesis in owl monkey cns and coronavirus infection of owl monkey cns via peripheral routes

Susceptibility of murine cns to oc43 infection

Macrophage infiltration, but not apoptosis, is correlated with immune-mediated demyelination following murine infection with a neurotropic coronavirus

Astrocyte response to ifn-gamma limits il-6-mediated microglia activation and progressive autoimmune encephalomyelitis

Role of viral persistence in retaining cd8(+) t cells within the central nervous system

A central role for cd4(+) t cells and rantes in virusinduced central nervous system inflammation and demyelination

Ifn-gamma-inducible protein 10 (ip-10; cxcl10)-deficient mice reveal a role for ip-10 in effector t cell generation and trafficking

Neutralization of the chemokine cxcl10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis

Distinct gene profiles of bone marrow-derived macrophages and microglia during neurotropic coronavirus-induced demyelination

Activation of glial cells by human coronavirus oc43 infection

Nitric oxide synthase type ii expression by different cell types in mhv-jhm encephalitis suggests distinct roles for nitric oxide in acute versus persistent virus infection

Persistent coronavirus infection of progenitor oligodendrocytes

The Chemokine Receptor CXCR2 and Coronavirus-Induced Neurologic Disease

Interferon-gamma inhibits cell cycle exit in differentiating oligodendrocyte progenitor cells

Cxcr2 signaling protects oligodendrocyte progenitor cells from ifn-gamma/cxcl10-mediated apoptosis

Antibody prevents virus reactivation within the central nervous system

Control of central nervous system viral persistence by neutralizing antibody

Acute disseminated encephalomyelitis: Updates on an inflammatory cns syndrome

Acute disseminated encephalomyelitis in children: An updated review based on current diagnostic criteria

Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis

Utility of csf cytokine/chemokines as markers of active intrathecal inflammation: Comparison of demyelinating, anti-nmdar and enteroviral encephalitis

Multiple organ infection and the pathogenesis of sars

Possible central nervous system infection by sars coronavirus

Severe neurologic syndrome associated with middle east respiratory syndrome corona virus (mers-cov)

Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study. . Neurological manifestations of hospitalized patients with covid-19 in wuhan, china: A retrospective case series study

Neurologic complications of coronavirus infections

Patient-reported outcome questionnaires for the evaluation of olfactory and gustatory dysfunctions in covid-19

Covid-19-associated acute hemorrhagic necrotizing encephalopathy: Ct and mri features

Covid-19 presenting with seizures. IDCases

A first case of meningitis/encephalitis associated with sars-coronavirus-2

Sars-cov-2 can induce brain and spine demyelinating lesions

The neuroinvasive potential of sars-cov2 may play a role in the respiratory failure of covid-19 patients

Large artery ischaemic stroke in severe acute respiratory syndrome (sars)

Neurological manifestations in severe acute respiratory syndrome

Venous and arterial thromboembolic complications in covid-19 patients admitted to an academic hospital in milan, italy

Large-vessel stroke as a presenting feature of covid-19 in the young

Neurologic features in severe sars-cov-2 infection

More on neurologic features in severe sars-cov-2 infection. Reply

Prothrombotic phenotype in covid-19 severe patients

High risk of thrombosis in patients with severe sars-cov-2 infection: A multicenter prospective cohort study

Encephalopathy as the sentinel sign of a cortical stroke in a patient infected with coronavirus disease-19 (covid-19)

Covid-19 presenting as stroke

Incidence of thrombotic complications in critically ill icu patients with covid-19

Confirmation of the high cumulative incidence of thrombotic complications in critically ill icu patients with covid-19: An updated analysis

Thromboembolic risk and anticoagulant therapy in covid-19 patients: Emerging evidence and call for action

Section signrefers to: Camdessanche jp, morel j,pozzetto b, paul s. Covid-19 may induce guillain-barre syndrome.Covid-19 and guillain-barre syndrome : Response section sign

Guillain-barre syndrome following covid-19: New infection, old complication?

Guillain barre syndrome associated with covid-19 infection: A case report

Guillain-barre syndrome associated with sars-cov-2

Miller fisher syndrome and polyneuritis cranialis in covid-19

Human coronavirus oc43 infection induces chronic encephalitis leading to disabilities in balb/c mice

Intracisternal virus-like particles in brain of a multiple sclerosis patient

Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients

Coronaviruses sd and sk share extensive nucleotide homology with murine coronavirus mhv-a59, more than that shared between human and murine coronaviruses

Human coronavirus polyadenylated rna sequences in cerebrospinal fluid from multiple sclerosis patients

Detection of coronavirus rna and antigen in multiple sclerosis brain

Human coronavirus gene expression in the brains of multiple sclerosis patients

Myelin basic protein and human coronavirus 229e cross-reactive t cells in multiple sclerosis

Antibodies to coronaviruses oc43 and 229e in multiple sclerosis patients

Cerebrospinal fluid antibodies to coronavirus in patients with parkinson's disease

Role of cytokines in neurological disorders

The role of interleukin-6 signaling in nervous tissue

Interleukin-6, a major cytokine in the central nervous system

Does sars-cov-2 invade the brain? Translational lessons from animal models

Sars-cov-2: Underestimated damage to nervous system

How to detect and track chronic neurologic sequelae of covid-19? Use of auditory brainstem responses and neuroimaging for long-term patient follow-up